Product
TEV-48574
2 clinical trials
4 indications
Indication
Crohn's DiseaseIndication
ColitisIndication
UlcerativeIndication
AsthmaClinical trial
A 14 Week Phase 2b, Randomized, Double-Blind, Dose-Ranging Study to Determine the Pharmacokinetics, Efficacy, Safety and Tolerability of TEV-48574 in Adult Patients With Ulcerative Colitis or Crohn's Disease (RELIEVE UCCD)Status: Recruiting, Estimated PCD: 2024-12-16
Clinical trial
A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled AsthmaStatus: Terminated, Estimated PCD: 2022-01-17